ProQR Therapeutics Provides Update on Ophthalmic Assets Press release … company dedicated to changing lives through transformative RNA therapies today provided an update that its previously … our primary focus at ProQR remains on our Axiomer ® RNA editing platform,” said Daniel A. de Boer, Founder and … Setembro 27, 2023
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day Press release LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Janeiro 29, 2019